{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:37:18Z","timestamp":1789015038466,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"crossref","award":["6602-20"],"award-info":[{"award-number":["6602-20"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Multiple Myeloma (MM) is a hematological malignancy with genomic heterogeneity and poor survival outcome. Apart from the central role of genetic lesions, epigenetic anomalies have been identified as drivers in the development of the disease.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Alterations in the DNA methylome were mapped in 52 newly diagnosed MM (NDMM) patients of six molecular subgroups and matched with loci-specific chromatin marks to define their impact on gene expression. Differential DNA methylation analysis was performed using DMAP with a \u226510% increase (hypermethylation) or decrease (hypomethylation) in NDMM subgroups, compared to control samples, considered significant for all the subsequent analyses with p&lt;0.05 after adjusting for a false discovery rate.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We identified differentially methylated regions (DMRs) within the etiological cytogenetic subgroups of myeloma, compared to control plasma cells. Using gene expression data we identified genes that are dysregulated and correlate with DNA methylation levels, indicating a role for DNA methylation in their transcriptional control. We demonstrated that 70% of DMRs in the MM epigenome were hypomethylated and overlapped with repressive H3K27me3. In contrast, differentially expressed genes containing hypermethylated DMRs within the gene body or hypomethylated DMRs at the promoters overlapped with H3K4me1, H3K4me3, or H3K36me3 marks. Additionally, enrichment of BRD4 or MED1 at the H3K27ac enriched DMRs functioned as super-enhancers (SE), controlling the overexpression of genes or gene-cassettes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Therefore, this study presents the underlying epigenetic regulatory networks of gene expression dysregulation in NDMM patients and identifies potential targets for future therapies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13045-020-00933-y","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T08:04:34Z","timestamp":1596701074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma"],"prefix":"10.1186","volume":"13","author":[{"given":"Samrat Roy","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslana","family":"Tytarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayu","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Den","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Schinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Zangari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmilan","family":"Thanendrarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith E.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"van Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8615-6254","authenticated-orcid":false,"given":"Brian A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"933_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrc3257","volume":"12","author":"GJ Morgan","year":"2012","unstructured":"Morgan GJ, Walker BA, Davies FE. The genetic architecture of multiple myeloma. Nature Reviews Cancer. 2012;12:335. https:\/\/doi.org\/10.1038\/nrc3257.","journal-title":"Nature Reviews Cancer"},{"key":"933_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"GM Durie Brian","year":"1975","unstructured":"Durie Brian GM, Salmon Sydney E. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36:842\u201354. https:\/\/doi.org\/10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U.","journal-title":"Cancer"},{"key":"933_CR3","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan F, et al. The molecular classification of multiple myeloma. Blood. 2006;108:2020\u20138. https:\/\/doi.org\/10.1182\/blood-2005-11-013458.","journal-title":"Blood"},{"key":"933_CR4","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1038\/leu.2009.174","volume":"23","author":"R Fonseca","year":"2009","unstructured":"Fonseca R, et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia. 2009;23:2210. https:\/\/doi.org\/10.1038\/leu.2009.174.","journal-title":"Leukemia"},{"key":"933_CR5","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1182\/blood-2006-02-005496","volume":"108","author":"BA Walker","year":"2006","unstructured":"Walker BA, et al. Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood. 2006;108:1733.","journal-title":"Blood"},{"key":"933_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.29","volume":"4","author":"K Dimopoulos","year":"2014","unstructured":"Dimopoulos K, Gimsing P, Gr\u00f8nb\u00e6k K. The role of epigenetics in the biology of multiple myeloma. Blood Cancer Journal. 2014;4:e207. https:\/\/doi.org\/10.1038\/bcj.2014.29.","journal-title":"Blood Cancer Journal"},{"key":"933_CR7","doi-asserted-by":"crossref","unstructured":"Nobili, L. et al. Long Non-Coding RNAs in Multiple Myeloma. Genes (Basel) 9, doi:10.3390\/genes9020069 (2018).","DOI":"10.3390\/genes9020069"},{"key":"933_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1182\/blood-2010-04-279539","volume":"117","author":"BA Walker","year":"2011","unstructured":"Walker BA, et al. Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. Blood. 2011;117:553.","journal-title":"Blood"},{"key":"933_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1182\/blood-2013-03-487884","volume":"122","author":"MF Kaiser","year":"2013","unstructured":"Kaiser MF, et al. Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma. Blood. 2013;122:219.","journal-title":"Blood"},{"key":"933_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004566","volume":"10","author":"R Popovic","year":"2014","unstructured":"Popovic R, et al. Histone methyltransferase MMSET\/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet. 2014;10:e1004566. https:\/\/doi.org\/10.1371\/journal.pgen.1004566.","journal-title":"PLoS Genet"},{"key":"933_CR11","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1158\/0008-5472.CAN-10-0282","volume":"70","author":"B Salhia","year":"2010","unstructured":"Salhia B, et al. DNA methylation analysis determines the high frequency of genic hypomethylation and low frequency of hypermethylation events in plasma cell tumors. Cancer Res. 2010;70:6934\u201344. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0282.","journal-title":"Cancer Res"},{"key":"933_CR12","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/carcin\/bgp149","volume":"30","author":"V Bollati","year":"2009","unstructured":"Bollati V, et al. Differential repetitive DNA methylation in multiple myeloma molecular subgroups. Carcinogenesis. 2009;30:1330\u20135. https:\/\/doi.org\/10.1093\/carcin\/bgp149.","journal-title":"Carcinogenesis"},{"key":"933_CR13","doi-asserted-by":"crossref","unstructured":"Choudhury, S. R. & Walker, B. A. in Multiple Myeloma: Methods and Protocols (eds Christoph Heuck & Niels Weinhold) 179-191 (Springer New York, 2018).","DOI":"10.1007\/978-1-4939-7865-6_13"},{"key":"933_CR14","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/bioinformatics\/btu126","volume":"30","author":"PA Stockwell","year":"2014","unstructured":"Stockwell PA, Chatterjee A, Rodger EJ, Morison IM. DMAP: differential methylation analysis package for RRBS and WGBS data. Bioinformatics. 2014;30:1814\u201322. https:\/\/doi.org\/10.1093\/bioinformatics\/btu126.","journal-title":"Bioinformatics"},{"key":"933_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2012","unstructured":"Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012;29:15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635.","journal-title":"Bioinformatics"},{"key":"933_CR16","doi-asserted-by":"crossref","unstructured":"Patro, R., Duggal, G. & Kingsford, C. Salmon: Accurate, Versatile and Ultrafast Quantification from RNA-seq Data using Lightweight-Alignment. bioRxiv, 021592, doi:10.1101\/021592 (2015).","DOI":"10.1101\/021592"},{"key":"933_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011471","volume":"5","author":"EG Wilbanks","year":"2010","unstructured":"Wilbanks EG, Facciotti MT. Evaluation of algorithm performance in ChIP-seq peak detection. PloS one. 2010;5:e11471.","journal-title":"PloS one"},{"key":"933_CR18","doi-asserted-by":"crossref","unstructured":"Zang, C. et al. A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics (Oxford, England) 25, 1952-1958, doi:10.1093\/bioinformatics\/btp340 (2009).","DOI":"10.1093\/bioinformatics\/btp340"},{"key":"933_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13059-015-0736-8","volume":"16","author":"EM Pugacheva","year":"2015","unstructured":"Pugacheva EM, et al. Comparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions. Genome Biology. 2015;16:161. https:\/\/doi.org\/10.1186\/s13059-015-0736-8.","journal-title":"Genome Biology"},{"key":"933_CR20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n J, et al. Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers. Cell. 2013;153:320\u201334. https:\/\/doi.org\/10.1016\/j.cell.2013.03.036.","journal-title":"Cell"},{"key":"933_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2014.07.028","volume":"26","author":"X Yang","year":"2014","unstructured":"Yang X, et al. Gene Body Methylation can alter Gene Expression and is a Therapeutic Target in Cancer. Cancer cell. 2014;26:577\u201390. https:\/\/doi.org\/10.1016\/j.ccr.2014.07.028.","journal-title":"Cancer cell"},{"key":"933_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrg2341","volume":"9","author":"MM Suzuki","year":"2008","unstructured":"Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nature Reviews Genetics. 2008;9:465. https:\/\/doi.org\/10.1038\/nrg2341.","journal-title":"Nature Reviews Genetics"},{"key":"933_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrg2005","volume":"8","author":"M Esteller","year":"2007","unstructured":"Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nature Reviews Genetics. 2007;8:286. https:\/\/doi.org\/10.1038\/nrg2005.","journal-title":"Nature Reviews Genetics"},{"key":"933_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genetics. 2003;33:245. https:\/\/doi.org\/10.1038\/ng1089.","journal-title":"Nature Genetics"},{"key":"933_CR25","doi-asserted-by":"crossref","unstructured":"Rose, N. R. & Klose, R. J. Understanding the relationship between DNA methylation and histone lysine methylation. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1839, 1362-1372 (2014).","DOI":"10.1016\/j.bbagrm.2014.02.007"},{"key":"933_CR26","doi-asserted-by":"publisher","unstructured":"Schuettengruber, B., Chourrout, D., Vervoort, M., Leblanc, B. & Cavalli, G. Genome Regulation by Polycomb and Trithorax Proteins. Cell 128, 735-745, doi:https:\/\/doi.org\/10.1016\/j.cell.2007.02.009 (2007).","DOI":"10.1016\/j.cell.2007.02.009"},{"key":"933_CR27","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1038\/emboj.2011.295","volume":"30","author":"A Pekowska","year":"2011","unstructured":"Pekowska A, et al. H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO J. 2011;30:4198\u2013210. https:\/\/doi.org\/10.1038\/emboj.2011.295.","journal-title":"EMBO J"},{"key":"933_CR28","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/sj.leu.2403347","volume":"18","author":"EK Grand","year":"2004","unstructured":"Grand EK, Chase AJ, Heath C, Rahemtulla A, Cross NCP. Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074. Leukemia. 2004;18:962. https:\/\/doi.org\/10.1038\/sj.leu.2403347.","journal-title":"Leukemia"},{"key":"933_CR29","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1182\/blood-2009-12-261032","volume":"116","author":"A Broyl","year":"2010","unstructured":"Broyl A, et al. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. Blood. 2010;116:2543\u201353. https:\/\/doi.org\/10.1182\/blood-2009-12-261032.","journal-title":"Blood"},{"key":"933_CR30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","volume":"106","author":"PL Bergsagel","year":"2005","unstructured":"Bergsagel PL, et al. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood. 2005;106:296\u2013303. https:\/\/doi.org\/10.1182\/blood-2005-01-0034.","journal-title":"Blood"},{"key":"933_CR31","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1182\/blood-2016-03-706077","volume":"128","author":"Y-W Qiang","year":"2016","unstructured":"Qiang Y-W, et al. MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma. Blood. 2016;128:2919\u201330. https:\/\/doi.org\/10.1182\/blood-2016-03-706077.","journal-title":"Blood"},{"key":"933_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13059-016-0879-2","volume":"17","author":"H Heyn","year":"2016","unstructured":"Heyn H, et al. Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer. Genome biology. 2016;17:11. https:\/\/doi.org\/10.1186\/s13059-016-0879-2.","journal-title":"Genome biology"},{"key":"933_CR33","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/ng.3291","volume":"47","author":"M Kulis","year":"2015","unstructured":"Kulis M, et al. Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat Genet. 2015;47:746\u201356. https:\/\/doi.org\/10.1038\/ng.3291.","journal-title":"Nat Genet"},{"key":"933_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1182\/blood-2010-07-298349","volume":"117","author":"E Martinez-Garcia","year":"2011","unstructured":"Martinez-Garcia E, et al. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood. 2011;117:211.","journal-title":"Blood"},{"key":"933_CR35","doi-asserted-by":"crossref","unstructured":"Pawlyn, C. et al. The spectrum and clinical impact of epigenetic modifier mutations in myeloma. Clinical Cancer Research, clincanres. 1790.2015 (2016).","DOI":"10.1016\/j.clml.2015.07.244"},{"key":"933_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/nar\/gkt875","volume":"42","author":"G Luo","year":"2013","unstructured":"Luo G, Lou H, Wise JA, Zhou H-L. Regulation of alternative splicing by local histone modifications: potential roles for RNA-guided mechanisms. Nucleic Acids Research. 2013;42:701\u201313. https:\/\/doi.org\/10.1093\/nar\/gkt875.","journal-title":"Nucleic Acids Research"},{"key":"933_CR37","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.1184208","volume":"327","author":"RF Luco","year":"2010","unstructured":"Luco RF, et al. Regulation of alternative splicing by histone modifications. Science. 2010;327:996\u20131000.","journal-title":"Science"},{"key":"933_CR38","doi-asserted-by":"publisher","first-page":"13564","DOI":"10.1073\/pnas.1109475108","volume":"108","author":"S Kim","year":"2011","unstructured":"Kim S, Kim H, Fong N, Erickson B, Bentley DL. Pre-mRNA splicing is a determinant of histone H3K36 methylation. Proc Natl Acad Sci U S A. 2011;108:13564\u20139. https:\/\/doi.org\/10.1073\/pnas.1109475108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"933_CR39","doi-asserted-by":"crossref","unstructured":"Le, K.-q., Prabhakar, B. S., Hong, W.-j. & Li, L.-c. Alternative splicing as a biomarker and potential target for drug discovery. Acta Pharmacologica Sinica 36, 1212 (2015).","DOI":"10.1038\/aps.2015.43"},{"key":"933_CR40","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1080\/10428194.2017.1421760","volume":"59","author":"V Ramakrishnan","year":"2018","unstructured":"Ramakrishnan V, Kumar S. PI3K\/AKT\/mTOR pathway in multiple myeloma: from basic biology to clinical promise. Leukemia & lymphoma. 2018;59:2524\u201334. https:\/\/doi.org\/10.1080\/10428194.2017.1421760.","journal-title":"Leukemia & lymphoma"},{"key":"933_CR41","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1038\/leu.2017.141","volume":"31","author":"H Ohguchi","year":"2017","unstructured":"Ohguchi H, et al. KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival. Leukemia. 2017;31:2661\u20139. https:\/\/doi.org\/10.1038\/leu.2017.141.","journal-title":"Leukemia"},{"key":"933_CR42","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.3892\/ol.2017.6723","volume":"14","author":"Z Liu","year":"2017","unstructured":"Liu Z, et al. Network-based analysis of the molecular mechanisms of multiple myeloma and monoclonal gammopathy of undetermined significance. Oncol Lett. 2017;14:4167\u201375. https:\/\/doi.org\/10.3892\/ol.2017.6723.","journal-title":"Oncol Lett"},{"key":"933_CR43","doi-asserted-by":"crossref","unstructured":"Choudhury, S. R., Cui, Y., Lubecka, K., Stefanska, B. & Irudayaraj, J. CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter. Oncotarget 7, 46545-46556, doi:10.18632\/oncotarget.10234 (2016).","DOI":"10.18632\/oncotarget.10234"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-020-00933-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-020-00933-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-020-00933-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:10:46Z","timestamp":1628208646000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-020-00933-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1186\/s13045-020-00933-y","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"assertion":[{"value":"17 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the University of Arkansas for Medical Sciences under protocol number 260284.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}